Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CFTR Correctors and Antioxidants Partially Normalize Lipid Imbalance but not Abnormal Basal Inflammatory Cytokine Profile in CF Bronchial Epithelial Cells
Mieke Veltman, Juan Bautista De Sanctis, Marta Stolarczyk, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Effect of elexacaftor-tezacaftor-ivacaftor on body weight and metabolic parameters in adults with cystic fibrosis
Max C. Petersen, Lauren Begnel, Michael Wallendorf, et al.
Journal of Cystic Fibrosis (2021) Vol. 21, Iss. 2, pp. 265-271
Open Access | Times Cited: 122
Elexacaftor-Tezacaftor-Ivacaftor: A Life-Changing Triple Combination of CFTR Modulator Drugs for Cystic Fibrosis
Mafalda Bacalhau, Mariana Camargo, Grace Anne Vieira Magalhães Ghiotto, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 410-410
Open Access | Times Cited: 61
Proteomics profiling of inflammatory responses to elexacaftor/tezacaftor/ivacaftor in cystic fibrosis
Hazel Ozuna, Dinesh Bojja, Santiago Partida‐Sánchez, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 2
CFTR Protein: Not Just a Chloride Channel?
L. Hanssens, Jean Duchateau, Georges Casimir
Cells (2021) Vol. 10, Iss. 11, pp. 2844-2844
Open Access | Times Cited: 78
Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapy
Katherine B. Hisert, Susan E. Birket, John P. Clancy, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 10, pp. 916-931
Closed Access | Times Cited: 35
Cystic Fibrosis and Oxidative Stress: The Role of CFTR
Evelina Moliteo, Monica Sciacca, Antonino Palmeri, et al.
Molecules (2022) Vol. 27, Iss. 16, pp. 5324-5324
Open Access | Times Cited: 32
Cystic fibrosis and fat malabsorption: Pathophysiology of the cystic fibrosis gastrointestinal tract and the impact of highly effective CFTR modulator therapy
Catherine M. McDonald, Elizabeth K. Reid, John F. Pohl, et al.
Nutrition in Clinical Practice (2024) Vol. 39, Iss. S1
Open Access | Times Cited: 6
Pulmonary Ionocytes Regulate Airway Surface Liquid pH in Primary Human Bronchial Epithelial Cells
Xiaojie Luan, N. Henao Romero, Verónica A. Campanucci, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 210, Iss. 6, pp. 788-800
Closed Access | Times Cited: 6
Human Mesenchymal Stem Cell Therapy: Potential Advances for Reducing Cystic Fibrosis Infection and Organ Inflammation
Tracey L. Bonfield, Hillard M. Lazarus
Best Practice & Research Clinical Haematology (2025) Vol. 38, Iss. 1, pp. 101602-101602
Closed Access
Genetic Architecture of Hock Joint Bumps in Pigs: Insights from ROH and GWAS Analyses
Lyubov Getmantseva, Maria Kolosova, Varvara Shevtsova, et al.
Animals (2025) Vol. 15, Iss. 8, pp. 1178-1178
Open Access
Wound repair and immune function in the Pseudomonas infected CF lung: before and after highly effective modulator therapy
E. Matthews, Meghan June Hirsch, Federico Prokopczuk, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Elexacaftor/tezacaftor/ivacaftor treatment reduces airway inflammation in cystic fibrosis
Richard C. De Vuyst, Erin Bennard, Charissa W. Kam, et al.
Pediatric Pulmonology (2023) Vol. 58, Iss. 5, pp. 1592-1594
Open Access | Times Cited: 9
Lipid-driven CFTR clustering is impaired in cystic fibrosis and restored by corrector drugs
Asmahan Abu‐Arish, Elvis Pandžić, Yishan Luo, et al.
Journal of Cell Science (2022) Vol. 135, Iss. 5
Open Access | Times Cited: 16
Update on Innate and Adaptive Immunity in Cystic Fibrosis
Emanuela M. Bruscia, Tracey L. Bonfield
Clinics in Chest Medicine (2022) Vol. 43, Iss. 4, pp. 603-615
Closed Access | Times Cited: 16
Links between Disease Severity, Bacterial Infections and Oxidative Stress in Cystic Fibrosis
Sabina Galiniak, Mateusz Mołoń, Marta Rachel
Antioxidants (2022) Vol. 11, Iss. 5, pp. 887-887
Open Access | Times Cited: 14
A compensatory RNase E variation increases Iron Piracy and Virulence in multidrug-resistant Pseudomonas aeruginosa during Macrophage infection
Mylène Vaillancourt, Anna Clara Milesi Galdino, Sam P. Limsuwannarot, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 4, pp. e1010942-e1010942
Open Access | Times Cited: 8
Changes in nutrition and growth status in young children in the first 12 weeks of ivacaftor therapy
Alyssa Tindall, Rosara Bass, Asim Maqbool, et al.
Journal of Cystic Fibrosis (2023) Vol. 22, Iss. 6, pp. 989-995
Closed Access | Times Cited: 8
CFTR modulator therapy alters plasma sphingolipid profiles in people with cystic fibrosis
Dirk Westhölter, Fabian Schumacher, Nuria Wülfinghoff, et al.
Journal of Cystic Fibrosis (2022) Vol. 21, Iss. 4, pp. 713-720
Open Access | Times Cited: 13
Nutrition in Cystic Fibrosis—Some Notes on the Fat Recommendations
Birgitta Strandvik
Nutrients (2022) Vol. 14, Iss. 4, pp. 853-853
Open Access | Times Cited: 13
CF Patients’ Airway Epithelium and Sex Contribute to Biosynthesis Defects of Pro-Resolving Lipids
Mickaël Shum, Charlie London, Maëlle Briottet, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Improvement of lipid and lipoprotein profiles in children and adolescents with cystic fibrosis on CFTR modulator therapy
Tatiana Yuzyuk, Catherine M. McDonald, Lauren M. Zuromski, et al.
Journal of Cystic Fibrosis (2023) Vol. 22, Iss. 6, pp. 1027-1035
Closed Access | Times Cited: 6
α-Tocopherol Pharmacokinetics in Adults with Cystic Fibrosis: Benefits of Supplemental Vitamin C Administration
Maret G. Traber, Scott W. Leonard, Vihas T. Vasu, et al.
Nutrients (2022) Vol. 14, Iss. 18, pp. 3717-3717
Open Access | Times Cited: 9
The fatty acid imbalance of cystic fibrosis exists at birth independent of feeding in pig and ferret models
Aliye Uç, Birgitta Strandvik, Jianrong Yao, et al.
Clinical Science (2022) Vol. 136, Iss. 24, pp. 1773-1791
Open Access | Times Cited: 8
Sphingomyelinase decreases transepithelial anion secretion in airway epithelial cells in part by inhibiting CFTR‐mediated apical conductance
Kirsten A. Cottrill, Raven J. Peterson, Colby F. Lewallen, et al.
Physiological Reports (2021) Vol. 9, Iss. 15
Open Access | Times Cited: 11
Impact of lumacaftor/ivacaftor on nutrition and growth in modulator-naïve children over 24 weeks
Alyssa Tindall, Rosara Bass, Asim Maqbool, et al.
Journal of Cystic Fibrosis (2024) Vol. 23, Iss. 4, pp. 758-763
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top